234 related articles for article (PubMed ID: 22013166)
21. Positive supercoiling of mitotic DNA drives decatenation by topoisomerase II in eukaryotes.
Baxter J; Sen N; Martínez VL; De Carandini ME; Schvartzman JB; Diffley JF; Aragón L
Science; 2011 Mar; 331(6022):1328-32. PubMed ID: 21393545
[TBL] [Abstract][Full Text] [Related]
22. The G2-phase decatenation checkpoint is defective in Werner syndrome cells.
Franchitto A; Oshima J; Pichierri P
Cancer Res; 2003 Jun; 63(12):3289-95. PubMed ID: 12810661
[TBL] [Abstract][Full Text] [Related]
23. Selective killing of G2 decatenation checkpoint defective colon cancer cells by catalytic topoisomerase II inhibitor.
Jain CK; Roychoudhury S; Majumder HK
Biochim Biophys Acta; 2015 May; 1853(5):1195-204. PubMed ID: 25746763
[TBL] [Abstract][Full Text] [Related]
24. Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle.
Pichierri P; Franchitto A; Mosesso P; Proietti de Santis L; Balajee AS; Palitti F
Mutat Res; 2000 Mar; 459(2):123-33. PubMed ID: 10725663
[TBL] [Abstract][Full Text] [Related]
25. PTEN stabilizes TOP2A and regulates the DNA decatenation.
Kang X; Song C; Du X; Zhang C; Liu Y; Liang L; He J; Lamb K; Shen WH; Yin Y
Sci Rep; 2015 Dec; 5():17873. PubMed ID: 26657567
[TBL] [Abstract][Full Text] [Related]
26. Centromere DNA decatenation depends on cohesin removal and is required for mammalian cell division.
Wang LH; Mayer B; Stemmann O; Nigg EA
J Cell Sci; 2010 Mar; 123(Pt 5):806-13. PubMed ID: 20144989
[TBL] [Abstract][Full Text] [Related]
27. The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα.
Yalowich JC; Wu X; Zhang R; Kanagasabai R; Hornbaker M; Hasinoff BB
Biochem Pharmacol; 2012 Jul; 84(1):52-8. PubMed ID: 22503743
[TBL] [Abstract][Full Text] [Related]
28. The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.
Kwon Y; Shin BS; Chung IK
J Biol Chem; 2000 Jun; 275(24):18503-10. PubMed ID: 10764786
[TBL] [Abstract][Full Text] [Related]
29. BRCA1 participates in DNA decatenation.
Lou Z; Minter-Dykhouse K; Chen J
Nat Struct Mol Biol; 2005 Jul; 12(7):589-93. PubMed ID: 15965487
[TBL] [Abstract][Full Text] [Related]
30. HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity.
Stros M; Bacíková A; Polanská E; Stokrová J; Strauss F
Nucleic Acids Res; 2007; 35(15):5001-13. PubMed ID: 17636313
[TBL] [Abstract][Full Text] [Related]
31. PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis.
Nielsen CF; Huttner D; Bizard AH; Hirano S; Li TN; Palmai-Pallag T; Bjerregaard VA; Liu Y; Nigg EA; Wang LH; Hickson ID
Nat Commun; 2015 Dec; 6():8962. PubMed ID: 26643143
[TBL] [Abstract][Full Text] [Related]
32. Identification of toposome, a novel multisubunit complex containing topoisomerase IIalpha.
Lee CG; Hague LK; Li H; Donnelly R
Cell Cycle; 2004 May; 3(5):638-47. PubMed ID: 15034300
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel catalytic inhibitor of topoisomerase II alpha that engages distinct mechanisms in p53
Lee SF; Hirpara JL; Qu J; Yadav SK; Sachaphibulkij K; Pervaiz S
Cancer Lett; 2022 Feb; 526():284-303. PubMed ID: 34843865
[TBL] [Abstract][Full Text] [Related]
34. Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells.
Pourpak A; Landowski TH; Dorr RT
J Pharmacol Exp Ther; 2007 Jun; 321(3):1109-17. PubMed ID: 17351106
[TBL] [Abstract][Full Text] [Related]
35. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
[TBL] [Abstract][Full Text] [Related]
36. Telomerase-associated protein 1, HSP90, and topoisomerase IIalpha associate directly with the BLM helicase in immortalized cells using ALT and modulate its helicase activity using telomeric DNA substrates.
Bhattacharyya S; Keirsey J; Russell B; Kavecansky J; Lillard-Wetherell K; Tahmaseb K; Turchi JJ; Groden J
J Biol Chem; 2009 May; 284(22):14966-77. PubMed ID: 19329795
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage.
Yoshida K; Yamaguchi T; Shinagawa H; Taira N; Nakayama KI; Miki Y
Mol Cell Biol; 2006 May; 26(9):3414-31. PubMed ID: 16611985
[TBL] [Abstract][Full Text] [Related]
38. Structural analysis of human chromosomes by atomic force and light microscopy in relation to the distribution of topoisomerase IIα.
Hoshi O; Ushiki T
Arch Histol Cytol; 2009; 72(4-5):245-9. PubMed ID: 21471659
[TBL] [Abstract][Full Text] [Related]
39. Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.
Popuri V; Tadokoro T; Croteau DL; Bohr VA
Crit Rev Biochem Mol Biol; 2013; 48(3):289-99. PubMed ID: 23627586
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin.
Zhao Y; Wang C; Wu Z; Fang J; Zhu L
Invest New Drugs; 2012 Feb; 30(1):17-24. PubMed ID: 20697773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
